Gene Therapy of Cancer: A Pilot Study of IL-4-Gene-Modified Fibroblasts Admixed with Autologous Tumor to Elicit an Immune Response. University of Pittsburgh
- 1 January 1994
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 5 (1), 41-55
- https://doi.org/10.1089/hum.1994.5.1-41
Abstract
The only peer-reviewed journal focused on the rapidly moving field of 3D printing and related technologies, providing comprehensive coverage of academic research and industrial and commercial developments that have applications in medicine, education, food, and architecture.Keywords
This publication has 5 references indexed in Scilit:
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes.The Journal of Immunology, 1989
- Promotion of human T lymphocyte proliferation by IL-4.The Journal of Immunology, 1989
- Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigens.Journal of Clinical Oncology, 1988
- Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.Molecular and Cellular Biology, 1986